Literature DB >> 9775488

Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients.

R A Schneider1.   

Abstract

Cancer patients typically experience fatigue while undergoing treatment for their disease. This study was an effort to identify a reliable and economical measure of fatigue. In particular, scores on the five subscales of the Multidimensional Fatigue Inventory (MFI-20) were analyzed for internal consistency and then correlated with scores on the Rhoten Fatigue Inventory to establish a measure of validity. Moderate-to-high Cronbach alphas coefficients were established for the General Fatigue subscale of the MFI-20 using a sample of 97 rural oncology outpatients (1). Partial associations with the Rhoten Fatigue Scale lend evidence to the validity of the MFI-20 measures.

Entities:  

Mesh:

Year:  1998        PMID: 9775488     DOI: 10.1097/00002820-199810000-00009

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  12 in total

1.  Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer.

Authors:  Jun Tian; Jin-Sheng Hong
Journal:  Support Care Cancer       Date:  2011-12-24       Impact factor: 3.603

2.  Reliability, responsiveness, and validity of the visual analog fatigue scale to measure exertion fatigue in people with chronic stroke: a preliminary study.

Authors:  Benjamin Y Tseng; Byron J Gajewski; Patricia M Kluding
Journal:  Stroke Res Treat       Date:  2010-05-16

Review 3.  A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples.

Authors:  B D Thombs; M Bassel; L McGuire; M T Smith; M Hudson; J A Haythornthwaite
Journal:  Rheumatology (Oxford)       Date:  2008-08-13       Impact factor: 7.580

4.  Biopsychosocial determinants of physical and mental fatigue in patients with spondyloarthropathy.

Authors:  Deborah Da Costa; Michel Zummer; Mary-Ann Fitzcharles
Journal:  Rheumatol Int       Date:  2009-12-20       Impact factor: 2.631

Review 5.  Cancer-related fatigue: role of oncology nurses in translating National Comprehensive Cancer Network assessment guidelines into practice.

Authors:  Barbara F Piper; Tami Borneman; Virginia Chih-Yi Sun; Marianna Koczywas; Gwen Uman; Betty Ferrell; Raysenia L James
Journal:  Clin J Oncol Nurs       Date:  2008-10       Impact factor: 1.027

6.  Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial.

Authors:  Eva K Horn; Tjeerd B van Benthem; Leona Hakkaart-van Roijen; Harm W J van Marwijk; Aartjan T F Beekman; Frans F Rutten; Christina M van der Feltz-Cornelis
Journal:  BMC Health Serv Res       Date:  2007-02-26       Impact factor: 2.655

7.  Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomised clinical trial.

Authors:  Marjoliek A IJff; Klaas M L Huijbregts; Harm W J van Marwijk; Aartjan T F Beekman; Leona Hakkaart-van Roijen; Frans F Rutten; Jürgen Unützer; Christina M van der Feltz-Cornelis
Journal:  BMC Health Serv Res       Date:  2007-03-01       Impact factor: 2.655

8.  Further validation of the Multidimensional Fatigue Inventory in a US adult population sample.

Authors:  Jin-Mann S Lin; Dana J Brimmer; Elizabeth M Maloney; Ernestina Nyarko; Rhonda Belue; William C Reeves
Journal:  Popul Health Metr       Date:  2009-12-15

9.  The acquiescence effect in responding to a questionnaire.

Authors:  Andreas Hinz; Dominik Michalski; Reinhold Schwarz; Philipp Yorck Herzberg
Journal:  Psychosoc Med       Date:  2007-06-20

10.  Validation of the Multidimensional Fatigue Inventory with Coronary Artery Disease Patients.

Authors:  Julija Gecaite-Stonciene; Adomas Bunevicius; Julius Burkauskas; Julija Brozaitiene; Julius Neverauskas; Narseta Mickuviene; Nijole Kazukauskiene
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.